Featured Research

from universities, journals, and other organizations

Jefferson Scientists Find Evidence Of Greater Sensitivity To Addictive Drugs In Adolescence

Date:
November 4, 2002
Source:
Thomas Jefferson University
Summary:
Researchers at Jefferson Medical College have evidence in animals that the young, adolescent brain may be more sensitive to addictive drugs such as cocaine and amphetamines than either the adult or newborn. The work may help someday lead to a better understanding of how the adolescent human brain adapts to such drugs, and provide clues into changes in the brain that occur during drug addiction.

Researchers at Jefferson Medical College have evidence in animals that the young, adolescent brain may be more sensitive to addictive drugs such as cocaine and amphetamines than either the adult or newborn. The work may help someday lead to a better understanding of how the adolescent human brain adapts to such drugs, and provide clues into changes in the brain that occur during drug addiction.

Scientists led by Michelle Ehrlich, M.D., professor of neurology at Jefferson Medical College of Thomas Jefferson University in Philadelphia and a member of the Farber Institute for Neurosciences at Jefferson, and Ellen Unterwald, Ph.D., associate professor of pharmacology at the Temple University School of Medicine in Philadelphia, found a greater increase in a certain protein in the part of the adolescent mouse brain called the striatum following chronic exposure to drugs such as amphetamine or cocaine than they did in either very young mice or adults.

Such psychostimulant drugs affect the brain's striatum in different ways, potentially affecting both movement and locomotion, or the "reward" system. This "molecular adaptation," says Dr. Ehrlich, could be significant. "An increase in this protein may be important because it could also affect other molecules that could lead to long-lasting changes in the brain in response to psychostimulant drugs." The protein, called Delta FosB, is a transcription factor and plays a role in regulating gene expression. Earlier research by other scientists had shown increased amounts of Delta FosB in adult brains following chronic exposure to psychostimulants.

The team, which includes scientists at the Nathan Kline Institute in Orangeburg, New York, reports its findings November 1 in the Journal of Neuroscience.

"Periadolescence and adolescence are when addiction usually begins, so we will be looking to see if this increase is a clue to sensitivity to addiction and sensitivity to such drugs as therapeutic agents," says Dr. Ehrlich.

"Many molecules have been implicated in both therapeutic and addictive responses to psychostimulants," she notes. Dr. Ehrlich's team examined how the mice responded to cocaine and amphetamine. They looked at the effects of the drugs on Delta FosB in three different age groups: post-weanling, or day 22; adolescent, days 33-43; and adult, or about six weeks of age. Each group was given cocaine, amphetamine or saline.

They found that in the adult, Delta FosB was increased in the caudate nucleus, part of the striatum associated with motor activity, particularly hyperactivity and attention deficit syndrome. They did not see similar increases in the accumbens, another part of the striatum that is associated with reward from psychostimulants. In the post-weanling mice, there was an increased response in the caudate only to amphetamine.

When they looked at the adolescent mice, they found Delta FosB was made in increased amounts in both areas of the brain in response to the drugs.

"The implications are that there is an increased adaptation in the younger brain than in the older brain to these psychostimulants," she says.

The results raise several questions. "What are the behavioral correlates of this increase in protein activity?" says Dr. Ehrlich. "Does this make them more prone to self-administer psychostimulants, meaning these mice could be a model of addiction? Does this make them more prone to hyperactivity? Are they more tolerant of higher doses of medication? These questions are relevant to addiction and to therapeutic use of these medications in these age groups."

Dr. Ehrlich and her co-workers have begun looking at the causes of such adaptations in the brain. They are studying some of the specific molecules involved in new mouse models. "At this point, many of the drugs that are being used therapeutically and in the treatment of addiction are being targeted to very restricted molecules," she says. "The question is, would they be better targeted to other molecules?"


Story Source:

The above story is based on materials provided by Thomas Jefferson University. Note: Materials may be edited for content and length.


Cite This Page:

Thomas Jefferson University. "Jefferson Scientists Find Evidence Of Greater Sensitivity To Addictive Drugs In Adolescence." ScienceDaily. ScienceDaily, 4 November 2002. <www.sciencedaily.com/releases/2002/11/021104064833.htm>.
Thomas Jefferson University. (2002, November 4). Jefferson Scientists Find Evidence Of Greater Sensitivity To Addictive Drugs In Adolescence. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2002/11/021104064833.htm
Thomas Jefferson University. "Jefferson Scientists Find Evidence Of Greater Sensitivity To Addictive Drugs In Adolescence." ScienceDaily. www.sciencedaily.com/releases/2002/11/021104064833.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins